My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Farmacia Hospitalaria
On-line version ISSN 2171-8695Print version ISSN 1130-6343
Abstract
SANCHEZ-CONDE, Matilde; VIVANCOS, María-Jesús and MORENO-GUILLEN, Santiago. Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties. Farm Hosp. [online]. 2017, vol.41, n.5, pp.630-637. ISSN 2171-8695. https://dx.doi.org/10.7399/fh.10821.
Despite the global stabilization of the number of new HIV infections in recent years, there has been an increase in new infections among men who have sex with men. This fact indicates the lack of effectiveness of the measures and prevention campaigns established so far for this group. It is therefore necessary to implement alternative preventive measures for them. Pre-exposure pharmacological prophylaxis (PrEP) is one of the best evaluated options and has had high protection rates in both clinical and real-life trials. The strategy has also shown an adequate profile in terms of safety, tolerance, adverse effects and cost-effectiveness in the studies carried out to assess this important topic
Keywords : Pre-exposure prophylaxis; HIV infection; Efficacy.